Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease

Thromb Res. 2020 Dec:196:106-108. doi: 10.1016/j.thromres.2020.08.023. Epub 2020 Aug 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Complement Membrane Attack Complex
  • Coronary Artery Disease* / complications
  • Humans
  • Risk Factors
  • Thrombophilia* / complications

Substances

  • Biomarkers
  • Complement Membrane Attack Complex